| Code | 5337C | ||||||||||
| MA number | 61/0299/17-S | ||||||||||
| Product Form: | sol rec 50x5 ml (obal LDPE-jednodáv.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | McNeil AB, Sweden | ||||||||||
| Therapeutic Class: | 61 - LAXANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | LDPE single-dose container | ||||||||||
| Route of admin.: | Rectal use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 06.10.2017 |
| SPC: |
SPC_Microlax_sol rec_04_2020.doc
|
| PIL: |
PIL_Microlax_sol rec_03_2024.pdf
|
| Safety feature | No |
| Data update: | 26.09.2022 |
